Nitric oxide (NO)-releasing pathway of FK409 in the presence of sulfhydryl-bearing compounds

被引:4
作者
Fukuyama, S [1 ]
Azuma, T [1 ]
Hirasawa, Y [1 ]
Morokoshi, N [1 ]
Akama, T [1 ]
Koda, S [1 ]
Kita, Y [1 ]
机构
[1] FUJISAWA PHARMACEUT CO LTD,NEW DRUG RES LABS,YODOGAWA KU,OSAKA 532,JAPAN
关键词
FK409; nitric oxide; L-cysteine; glutathione;
D O I
10.1023/A:1016076623060
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. We have recently reported that degradation of FK409 with generation of NO is spontaneous and is accelerated in the presence of sulfhydryl-bearing compounds, such as L-cysteine (Cys) and glutathione (GSH). The purpose of the present study is to investigate the NO-releasing pathway of FK409 in the presence of sulfhydryl-bearing compounds. Methods, The degradation process of FK409 in the presence of Cys or GSH was investigated by means of H-1-nuclear magnetic resonance (NMR) spectroscopy and high-performance liquid chromatography (HPLC). Results. The degradation of FK409 in the presence of Cys was dependent on concentration of Cys, and showed pH-dependency, accelerating with an increase in pH. The H-1-NMR spectra of FK409 with Cys suggested that time-dependent elimination of the hydrogen atom at the a-position of the nitro moiety (5-position) was accelerated by Cys in weakly alkaline solution. Cys and GSH were transformed readily, concomitant with FX409 degradation, to give their oxidized forms and probably S-nitrosothiols. Conclusion. The effect of sulfhydryl-bearing compounds on FK409 degradation is due to the acceleration of deprotonation of the hydrogen atom at the 5-position by thiolate anion as well as hydroxyl ion. Sulfhydryl-bearing compounds reacted with the released NO resulting in formation of disulfides via intermediate S-nitrosothiols.
引用
收藏
页码:1238 / 1242
页数:5
相关论文
共 15 条
[3]   CORRELATION BETWEEN NITRIC-OXIDE FORMATION DURING DEGRADATION OF ORGANIC NITRATES AND ACTIVATION OF GUANYLATE-CYCLASE [J].
FEELISCH, M ;
NOACK, EA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 139 (01) :19-30
[4]   A NEW NITRIC-OXIDE (NO) RELEASER - SPONTANEOUS NO RELEASE FROM FK409 [J].
FUKUYAMA, S ;
KITA, Y ;
HIRASAWA, Y ;
SATO, A ;
MOROKOSHI, N ;
KODA, S ;
YASUDA, T ;
OKA, S ;
SAKURAI, H .
FREE RADICAL RESEARCH, 1995, 23 (05) :443-452
[5]   Acceleration of nitric oxide (NO) release from FK409, a spontaneous NO releaser, in the presence of sulfhydryl-bearing compounds [J].
Fukuyama, S ;
Hirasawa, Y ;
Cox, D ;
Koda, S ;
Kita, Y .
PHARMACEUTICAL RESEARCH, 1995, 12 (12) :1948-1952
[6]   FK409, A NOVEL VASODILATOR ISOLATED FROM THE ACID-TREATED FERMENTATION BROTH OF STREPTOMYCES-GRISEOSPOREUS .1. TAXONOMY, FERMENTATION, ISOLATION, AND PHYSICOCHEMICAL AND BIOLOGICAL CHARACTERISTICS [J].
HINO, M ;
IWAMI, M ;
OKAMOTO, M ;
YOSHIDA, K ;
HARUTA, H ;
OKUHARA, M ;
HOSODA, J ;
KOHSAKA, M ;
AOKI, H ;
IMANAKA, H .
JOURNAL OF ANTIBIOTICS, 1989, 42 (11) :1578-1583
[7]  
IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739
[8]   NO FORMS AN ADDUCT WITH SERUM-ALBUMIN THAT HAS ENDOTHELIUM-DERIVED RELAXING FACTOR LIKE PROPERTIES [J].
KEANEY, JF ;
SIMON, DI ;
STAMLER, JS ;
JARAKI, O ;
SCHARFSTEIN, J ;
VITA, JA ;
LOSCALZO, J .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1582-1589
[9]   SPONTANEOUS NITRIC-OXIDE RELEASE ACCOUNTS FOR THE POTENT PHARMACOLOGICAL ACTIONS OF FK409 [J].
KITA, Y ;
HIRASAWA, Y ;
MAEDA, K ;
NISHIO, M ;
YOSHIDA, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 257 (1-2) :123-130
[10]   CLOSE CORRELATION BETWEEN NITRIC-OXIDE (NO) FORMATION FROM NO RELEASERS AND THE BIOLOGICAL-ACTIVITIES OF THESE AGENTS IN RATS [J].
KITA, Y ;
FUKUYAMA, S ;
HIRASAWA, Y .
JAPANESE JOURNAL OF PHARMACOLOGY, 1995, 69 (01) :69-74